These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34649345)

  • 1. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
    Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation.
    Chen C; Xia Y; Zhu S; Xu F; Sun Y; Lu H; Gao M; Yang Z; Mao Z; Ge Q; Miao Z; Zhu H; Yao P
    Virus Res; 2020 Sep; 286():198067. PubMed ID: 32553610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
    Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
    Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on biological characteristics of ten coxsackievirus A10 virus strains.
    Gao W; Yue L; Yang T; Li H; Song X; Xie T; He X; Xie Z
    Virology; 2021 Mar; 555():1-9. PubMed ID: 33418337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.
    Li J; Chang J; Liu X; Yang J; Guo H; Wei W; Zhang W; Yu XF
    J Gen Virol; 2014 May; 95(Pt 5):1083-1093. PubMed ID: 24496826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.
    Jiang Z; Zhang Y; Lin H; Cheng Q; Lu X; Liu W; Zhou R; Zhong B; Tian X
    Front Immunol; 2021; 12():665197. PubMed ID: 34054834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs.
    Zhang Z; Zhang X; Carr MJ; Zhou H; Li J; Liu S; Liu T; Xing W; Shi W
    Emerg Microbes Infect; 2019; 8(1):1445-1455. PubMed ID: 31595827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.
    Lien SC; Shen YS; Lin HY; Wu SR; Fang CY; Chen CH; Chen YA; Chong PC; Huang MH; Chow YH; Wang JR; Wu SC; Liu CC
    Virus Res; 2023 May; 329():199101. PubMed ID: 36958398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
    In HJ; Lim H; Lee JA; Kim HJ; Kim JW; Hyeon JY; Yeo SG; Lee JW; Yoo JS; Choi YK; Lee SW
    PLoS One; 2017; 12(5):e0178259. PubMed ID: 28542556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.
    Yang L; Mao Q; Li S; Gao F; Zhao H; Liu Y; Wan J; Ye X; Xia N; Cheng T; Liang Z
    Antiviral Res; 2016 Oct; 134():50-57. PubMed ID: 27582066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.